Brainsway Ltd. announced on January 12, 2026, that it received FDA approval for its Neurolief’s Proliv™Rx system, a treatment for Major Depressive Disorder.
AI Assistant
BRAINSWAY LTD
2026
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.